Back

DAPA ACT HF-TIMI 68: Dapagliflozin in Patients Hospitalized for Acute Heart Failure

30 August 2025 (08:15 - 08:25)
Organised by: Logo
Congress Presentation Part of: HOT LINE 2 Pharmacotherapy ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor David Berg

Brigham and Women's Hospital, Boston (United States of America)

10 More presentations in this session

Presentation thumbnail
Discussant review - DAPA ACT HF-TIMI 68
Professor B. Bozkurt (Houston, US)
Slides Video
Presentation thumbnail
Panel discussion - DAPA ACT HF-TIMI 68
Video
Presentation thumbnail
VICTOR: Vericiguat Global Study in Participants with Chronic Heart Failure
Professor F. Zannad (Vandoeuvre-Les-Nancy, FR)
Slides Video
Presentation thumbnail
VICTOR: Vericiguat Global Study in Participants with Chronic Heart Failure and VICTORIA: Vericiguat Global Study in Subjects with Heart Failure with Reduced Ejection Fraction
Professor J. Butler (Dallas, US)
Slides Video
Presentation thumbnail
Discussant review - VICTOR and VICTORIA
Professor J. McMurray (Glasgow, GB)
Slides Video

Access the full session

Session thumbnail
HOT LINE 2
Video

The Event

Event poster

ESC Congress 2025

30 August 2025 08:15 CET
You may be interested in
thumbnail
Congress Presentation
DIGIT-HF: Digitoxin in Patients with Heart Failure and Reduced Ejection Fraction
thumbnail
Congress Presentation
Discussant review - DAPA ACT HF-TIMI 68
thumbnail
Congress Presentation
VICTOR: Vericiguat Global Study in Participants with Chronic Heart Failure

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources